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Alcohol dependence is a severe and common disorder associated with high morbidity and mortality rates. Genetic
as well as environmental factors are known to modulate susceptibility to alcohol dependence. There is a growing
body of evidence suggesting that this interaction between the genome and the environment is mediated by
epigenetic mechanisms, e.g. DNA methylation at CpG sites. Following an introduction of epigenetic regulation of
gene transcription, this review will provide an overview over recent genetic and epigenetic findings in the context
of alcohol dependence focusing on human studies. Finally, we will discuss the current limitations of epigenetic
studies as well as the implications of genetic and epigenetic findings for the development of better treatment and
prevention strategies.
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Alcohol dependence is a severe disorder which con-
tributes substantially to the global burden of disease.
According to the World Health Organization (WHO) 2
billion individuals worldwide consume or abuse alcohol.
Alcohol consumption accounts for 3.2% of all deaths
worldwide, as well as for 4% of Disability Adjusted Life
Years (DALYs) which are expressed as the number of
years lost due to ill-health, disability, or early death
(WHO, 2002). Despite the deleterious effects of chronic
alcohol consumption, efficacy of preventive and thera-
peutic strategies still needs to be optimized.
The heritability of alcohol dependence is well recog-
nized and heritability estimates range between 40 and
70% [1-4]. However, the effects of the genetic risk var-
iants for psychiatric disorders, including alcohol de-
pendence, identified so far are small, and even after
consideration of polygenetic contributions they explain
only a small fraction of the estimated heritability of
psychiatric disorders. One possible explanation for this
“missing heritability” [5] might be the interaction be-
tween genes and environment mediated by epigenetic
mechanisms.
The aim of this review is to provide an overview of re-
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distribution, and reproduction in any mediumrole and importance of genetic and epigenetic factors in
alcohol dependence.Epigenetic mechanisms
Epigenetic mechanisms lead to functionally relevant
modifications of the genome as they induce stable chan-
ges in gene expression which consequently influence the
phenotypic outcome. These transcriptional control me-
chanisms, which can be heritable, are not accompanied
by nucleotide changes in the underlying DNA sequence.
Epigenetic mechanisms include histone modifications,
activities of noncoding RNA, and chemical alterations
of the DNA molecule itself. While the involvement of
DNA methylation in transcriptional regulation is a
long known phenomenon [6], the distinct role of 5-
hydroxymethylation in this process still has to be in-
vestigated [7-9]. In this review, we will focus on the
role of DNA methylation in epigenetic regulation of
gene expression.DNA methylation
DNA is methylated at position 5 of the cytosine py-
rimidine ring by transfer of the methyl group from
S-adenosyl methionine (SAM), a reaction catalyzed by
DNA methyltransferases (DNMTs). DNA methylation is
a stable chemical mark which is maintained through
cycles of cell division. DNA methylation mainly takes
place at CpG sites, nucleotide sequences consisting of antral Ltd. This is an Open Access article distributed under the terms of the
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in low frequency throughout the genome, but are
enriched in so called CpG islands, which are mainly
found in the promoter regions of genes near the tran-
scription start site. Promoter DNA methylation has been
strongly correlated with gene silencing, as the chemical
modification of the DNA is interfering with transcrip-
tion factor binding and attracts methyl-binding domain-
containing proteins, such as methyl CpG binding protein
2 (MeCP2), which act as transcriptional repressors [10].
However, more recent studies suggest that the pattern of
transcriptional regulation through DNA methylation is
more complex than previously anticipated [11]. Trad-
itionally it has been believed that DNA methylation pat-
terns are important for cell fate determination and that
they are fixed during embryonic development and cell
differentiation and remain stable afterwards [6]. Today it
is known that DNA methylation patterns are not as fixed
as previously thought, but can be influenced by environ-
mental factors and change over time [12]. Therefore,
regulation of gene transcription through DNA methyla-
tion which is mediated by environmental stimuli plays a
role in physiological responses as well as in adaptation
of the genome to environmental requirements. Factors
influencing DNA methylation are among others diet
(e.g. [13]), chemicals (e.g. [14]), drugs of abuse (e.g. [15]),
and even psychosocial factors like exposure to stress
(e.g. [16]).
Review
We conducted a systematic literature search using NCBI
PubMed (http://www.ncbi.nlm.nih.gov/pubmed/) and
keywords related to genetics and epigenetics of alcohol
abuse and dependence. Genome-wide association studies
in the context of alcohol dependence have been identi-
fied using the Catalog of Published Genome-wide associ-
ation studies (http://www.genome.gov/gwastudies/). We
included studies published prior to April 2013 in our re-
view. The reference sections of the chosen studies were
reviewed to detect additional studies we might have
missed in our literature search. Genetic studies, with a
strong focus on genome-wide results, will be reviewed
first, followed by a section on gene-environment interac-
tions, and finally a review of epigenetic studies in the
context of alcohol dependence. This part of the review
will first summarize recent candidate-gene based ap-
proaches followed by a report of the results of the two
epigenome-wide studies published to date. The last sec-
tion of the review will discuss recent findings on epige-
netics of alcohol withdrawal.
Genetics and epigenetics of alcohol dependence
The contribution of genetic factors to the development
of alcohol dependence is high [1-4] but nevertheless,knowledge about the specific genes underlying alcohol
dependence is currently very limited. The best classical
candidate genes for alcohol dependence are alcohol de-
hydrogenase (ADH) and aldehyde dehydrogenase (ALDH)
[17]. Both genes are involved in enzymatic degradation of
alcohol. Recently, the first genome-wide association stu-
dies (GWAS) on alcohol dependence have been published
[18-29].
These studies revealed some interesting new candidate
genes for alcohol dependence including cadherin 11
(CDH11) [22] and cadherin 13 (CDH13) [22,25], GATA
binding protein 4 (GATA4) [25], solute carrier family 22,
member 18 (SLC22A18) [19], and potassium large con-
ductance calcium-activated channel, subfamily M, alpha
member 1 gene (KCNMA1) [23]. Moreover, they pro-
vided further evidence for an association between ADH
and ALDH and alcohol dependence [20,23,25].
Results of a recent study by Yan et al. [30] investi-
gating the predictive value of the cumulative impact of
multiple genetic variants identified in previous candidate
as well as genome-wide studies, support a polygenic
model for alcohol dependence. This polygenic model of
inheritance involves many genetic variants of small ef-
fects to contribute to the risk of alcohol dependence.
Similar models of inheritance have been found for schi-
zophrenia and bipolar disorder [31] and might apply to
many other common complex diseases. However, this
study also showed that a positive family history of alco-
hol dependence was a better predictor for alcohol de-
pendence than the sum of genetic risk variants. This
finding illustrates that the genetic risk variants identified
so far can only explain a small fraction of the heritability
of alcohol dependence.
One possible explanation for this phenomenon of
“missing heritability” [5] is that beside the genome itself,
the cross-talk between the genome and the environment
is implicated in the etiology of alcohol dependence.
Gene-environment interactions have been reported for
the serotonin transporter (5-HTT) [32-35], the dopa-
mine receptor (DRD2)/ankyrin repeat and kinase
domain containing 1 (ANKK1) [36-38], catechol-O
-methyltransferase (COMT) [39,40], monoamine oxidase
(MAOA) [41-43], GABAA receptor (GABRA2) [44],
corticotrophin releasing hormone receptor 1 (CRHR1)
[45-48].
Gene-environment interactions can be mediated by
epigenetic mechanisms and evidence is emerging that al-
cohol consumption is one environmental factor which
may alter epigenetic signatures and thus related gene ex-
pression levels. Altered gene expression in brain reward
regions after alcohol intake has been reported, which
suggests that individual genes are differentially regulated
following alcohol consumption [49]. In actively drin-
king individuals, or individuals in early stages of alcohol
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found [50-54]. Homocysteine plays an important role in
DNA methylation as it is metabolized to methionine,
which is then activated to S-adenosyl methionine (SAM)
by ATP [55,56]. SAM is the most important methyl
group donor in transmethylation reactions in vertebrates,
including DNA methylation. Consequently, elevated ho-
mocysteine levels have been found to be associated with
increased levels of global as well as gene-specific DNA
methylation in alcohol dependent patients [57,58]. In
contradiction to this finding in alcohol dependent pa-
tients, other studies investigating human subjects reported
DNA hypomethylation to be associated with hyperhomo-
cysteinemic states [59-63].
Alterations in promoter DNA methylation levels in
alcohol dependent patients have been reported for
homocysteine-induced ER protein (HERP), alpha synu-
clein (SNCA), vasopressin (AVP), nerve growth factor
(NGF), atrial natriuretic peptide (ANP), N-methyl-D-as-
partate 2b receptor subtype (NR2B), MAOA, 5-HTT,
μ-opioid receptor (OPRM1), prodynorphin (PDYN), pro-
opiomelanocortin (POMC), dopamine transporter (DAT)
[64-75].
While some of these studies reported hypermethylation
in alcohol dependent patients (e.g. [64,66,67,70,71]), other
reported a hypomethylation of the gene region investi-
gated (e.g. [65,71]).
Recently, Zhang et al., [76] published an array-based
study investigating methylation levels of 384 CpGs in
82 candidate genes. The candidate genes have been
selected based on their involvement in brain neuro-
transmission systems (dopaminergic, opiodergic, se-
rotonergic, GABAergic/glutamatergic, cholinergic and
cannabinoidergic), in alcohol metabolism, DNA methy-
lation, or in signal transduction for alcohol reward and
reinforcement, or they have been found associated
with alcohol dependence in previous genetic studies.
CpGs in gamma-aminobutyric acid receptor subunit
beta-3 (GABRB3), pro-opiomelanocortin (POMC), neural
cell adhesion molecule 1 (NCAM1), dopamine recep-
tor D4 (DRD4), methyl-CpG-binding domain protein 3
(MBD3), 5-hydroxytryptamine receptor 3A (HTR3A) and
2B (HTR2B), and glutamate (NMDA) receptor subunit
zeta-1 (GRIN1) were found to be differentially methylated
in alcohol dependent patients compared to control sub-
jects, but only the result for one CpG site in the promoter
region of HTR3A withstood correction for multiple
testing.
The same CpG site showed nonsignificantly higher
methylation levels in a small replication sample, where
only 6 CpGs in HTR3A have been investigated. To con-
firm this preliminary finding of differential methylation
in HTR3A in alcohol dependence, additional studies will
be necessary.While these studies concentrated on candidate genes,
the first hypothesis free genome-wide investigations of
the effect of alcohol on DNA methylation have been cur-
rently published:
Philibert et al. conducted a genome-wide study on the
effect of recent alcohol use on the epigenome [77]. Here,
the authors compared DNA methylation of females
which did not consume alcohol in the last 6 months to
methylation patterns of females consuming alcohol
mildly (use of alcohol in between 1 and 8 weeks in the
last 6 month), moderately (use of alcohol in between 9
and 25 weeks in the last 6 month), or heavily (alcohol
use in every week in the last 6 month). By doing this,
they found the overall degree of methylation to be
(nonsignificantly) positively associated with the amount
of alcohol consumed. When the moderate and heavy
drinkers are pooled together and compared to the non-
consuming participants, a probe located in the active
BCR-related (ABR) gene, and in the 5` untranslated
region of the Bladder cancer-associated protein gene
(BLCAP) reached genome-wide significance after correc-
tion for multiple testing. However, only 4 of the heavy
drinkers investigated met the criteria for a lifetime diag-
nosis of alcohol dependence, therefore this result needs
further replication in a sample of alcohol dependent pa-
tients compared to control individuals.
The only epigenome-wide study investigating alcohol
dependent subjects has been published by Zhang et al.,
early this year [78]. In contrast to Phillibert et al., Zhang
et al., found the global methylation level, as well as the
majority of significantly differentially methylated CpG
sites, including the 50 most significant ones, to be hyop-
methylated in patients compared to healthy controls.
However, neither of these studies included a measure-
ment of homocysteine levels, which would have been
necessary to answer the question, whether DNA methy-
lation on an epigenome-wide level is associated with the
assumed elevated homocysteine levels in alcohol depen-
dent patients.
Further studies addressing this question in a hypothesis-
free genome-wide approach have to follow to clarify this
issue as well as to elucidate the effects of alcohol depen-
dence on the epigenome.
In addition to the elevated homocysteine levels in
actively drinking individuals [50-54], during alcohol
withdrawal, decreasing homocysteine levels have been
observed [50,51,53,79]. Under the assumption that ele-
vated homocysteine levels are associated with increased
levels of DNA methylation in alcohol dependent patients
[57,58], a plausible hypothesis is that methylation levels
also decrease during alcohol withdrawal. The first stu-
dies investigating the effects of alcohol withdrawal on
DNA methylation have been conducted applying a can-
didate gene approach [65,68,69]. These studies reported
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sing DNA methylation levels during alcohol withdrawal.
Biermann et al., [65] found a decrease of NR2B pro-
moter methylation during withdrawal, although this de-
crease did not reach significance. In contrast to that,
Heberlein et al., [68] investigating NGF, reported an in-
crease in promoter methylation, and in our own study,
we [69] did not detect an effect of alcohol withdrawal on
DAT promoter methylation.
Conclusions
There is a growing body of evidence highlighting the im-
portance of genetic and epigenetic factors in the de-
velopment and maintenance of alcohol dependence.
Nonetheless, by investigating epigenetic factors in alco-
hol dependence, some limitations have to be kept in
mind.
Most of the studies conducted thus far used peripheral
tissue instead of brain samples, mostly because access to
high quality brain material of well characterized alcohol
dependent subjects is very limited. While this is not an
issue in genetic studies, it might be a limitation in epi-
genetic research as epigenetic regulation is tissue- and
cell-type specific. However, as alcohol acts not only on
the brain but on the whole body, it could by hypothe-
sized that there might be a significant overlap between
methylation changes in the brain and blood, despite the
cell-type specific nature of DNA methylation patterns.
Moreover, the use of peripheral tissue is a valid approach
as it is necessary for the identification of biomarkers
with potential clinical usage. To identify those bio-
markers, we need a material which is easily accessibly
and can be studied in large samples of patients and con-
trol individuals. Peripheral blood is an adequate and
convenient tissue for that purpose.
As the field of epigenetic research is relatively new,
laboratory technologies still need to be optimized to
provide an unbiased method which I) requires small
amounts of input samples, II) is cost effective, and III)
will be able to reliably detect epigenetic marks with sin-
gle nucleotide resolution. In parallel with the improve-
ment of laboratory techniques, new analytical methods
and guidelines for quality control and analysis need to
be developed. The novelty of epigenetic research in alco-
hol dependence also explains the relatively small number
of studies published so far. In addition, a limited number
of research groups currently conduct epigenetic studies
in the field of alcohol dependence. The limitation of the
data available could explain the still heterogeneous na-
ture of the results regarding epigenetic effects of alcohol
dependence and withdrawal. Furthermore, the literature
is likely biased for positive associations, as negative find-
ings are infrequently published. Therefore, further genetic
and epigenetic research investigating large, homogenousgroups of patients and controls which are matched as
carefully as possible for confounding factors such as age,
sex, smoking and other environmental factors potentially
influencing epigenetic regulation are necessary. Despite
the previously mentioned difficulties that need to be
addressed in the near future, epigenetic studies have a
great potential to contribute to a better understanding of
the biological mechanisms underlying alcohol depen-
dence. A deeper insight into the epigenetic regulation of
alcohol dependence, withdrawal and relapse is needed to
develop better treatment and prevention strategies. In
addition, a better understanding of epigenetic regulation
might help to detect individuals at a higher risk to develop
alcohol dependence and/or identify alcohol dependent pa-
tients with a higher risk of relapse.
However, it has to be kept in mind that studies in-
vestigating epigenetics of withdrawal are currently very
limited so conclusions should therefore be drawn with
caution.
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